Novo to Launch Wegovy in Asia With February Roll-Out in Japan

Novo Nordisk will launch its hugely popular anti-obesity drug in Japan on February 22, its first launch in Asia, even as it struggles to keep up with demand in existing markets.

Related Keywords

United States ,Kobe ,Hyogo ,Japan ,Germany ,Norway ,Denmark ,Tokyo ,Copenhagen ,Køavn ,United Kingdom ,Danish ,Japanese ,Britain ,Eli Lilly ,Wataru Ogawa ,Mark Potter ,Jacob Gronholt Pedersen ,Jan Harvey ,Kobe University ,Japan Society For The Study Of Obesity ,Novo Nordisk ,Global Obesity ,East Asian ,Japan Society ,Rocky Swift ,Weight Management ,Obesity ,Bese ,Drug Shortages ,Medication Shortages ,Glp 1 Receptor Agonists ,Glucagon Like Peptide 1 Receptor Agonists ,Incretin Hormones ,Incretins ,Weight Loss ,